Geron director awarded 270,000 stock options
Geron Corp director Constantine Chinoporos received a grant of stock options, not an open-market share purchase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Geron Corp director Constantine Chinoporos received a grant of stock options, not an open-market share purchase. The award covers 270,000 options to buy Geron common stock at an exercise price of $1.57 per share and expires on March 24, 2036.
The options will vest in three equal annual installments starting on March 25, 2027, subject to his continuous service with the company through each vesting date. Following this grant, he holds 270,000 stock options directly according to the filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 270,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Geron (GERN) director Constantine Chinoporos report in this Form 4?
Is the Geron (GERN) Form 4 transaction a stock purchase or an option grant?
What are the vesting terms of Constantine Chinoporos’ options at Geron (GERN)?
When do Constantine Chinoporos’ Geron (GERN) stock options expire?
How many Geron (GERN) stock options does Constantine Chinoporos hold after this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.